These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2253341)

  • 1. The unique lipoprotein(a): properties and immunochemical measurement.
    Albers JJ; Marcovina SM; Lodge MS
    Clin Chem; 1990 Dec; 36(12):2019-26. PubMed ID: 2253341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The linkage with apolipoprotein (a) in lipoprotein (a) modifies the immunochemical and functional properties of apolipoprotein B.
    Zawadzki Z; Tercé F; Seman LJ; Theolis RT; Breckenridge WC; Milne RW; Marcel YL
    Biochemistry; 1988 Nov; 27(22):8474-81. PubMed ID: 2468359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lipoprotein(a): characteristics of a special lipoprotein and its potential clinical significance].
    Armstrong VW
    Ther Umsch; 1990 Jun; 47(6):475-81. PubMed ID: 2142832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a).
    Marcovina SM; Albers JJ; Gabel B; Koschinsky ML; Gaur VP
    Clin Chem; 1995 Feb; 41(2):246-55. PubMed ID: 7533064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lp(a) interactions.
    McConathy WJ; Trieu VN
    Prog Lipid Res; 1991; 30(2-3):195-203. PubMed ID: 1840454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a): a genetically determined cardiovascular pathogen in search of a function.
    Scanu AM
    J Lab Clin Med; 1990 Aug; 116(2):142-6. PubMed ID: 2144311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of fibrinolysis by lipoprotein(a).
    Anglés-Cano E; de la Peña Díaz A; Loyau S
    Ann N Y Acad Sci; 2001; 936():261-75. PubMed ID: 11460483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein(a): a genetically determined lipoprotein containing a glycoprotein of the plasminogen family.
    Scanu AM
    Semin Thromb Hemost; 1988 Jul; 14(3):266-70. PubMed ID: 2972066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein (a) measurements for clinical application.
    Marcovina SM; Albers JJ
    J Lipid Res; 2016 Apr; 57(4):526-37. PubMed ID: 26637278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipoprotein (a)--link between lipid metabolism and coagulation system?].
    Riesen WF
    Schweiz Med Wochenschr; 1991 Dec; 121(49):1813-8. PubMed ID: 1836645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic structure and organization of kringles type 3 to 10 of the apolipoprotein(a) gene in 6q26-27.
    Mihalich A; Magnaghi P; Sessa L; Trubia M; Acquati F; Taramelli R
    Gene; 1997 Sep; 196(1-2):1-8. PubMed ID: 9322734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological and clinical importance of lipoprotein(a).
    Romics L; Karádi I; Császár A; Kostner GM
    Tokai J Exp Clin Med; 1990 May; 15(2-3):149-54. PubMed ID: 2151833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein(a) as a risk factor for coronary artery disease.
    Marcovina SM; Koschinsky ML
    Am J Cardiol; 1998 Dec; 82(12A):57U-66U; discussion 86U. PubMed ID: 9915664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen.
    Eaton DL; Fless GM; Kohr WJ; McLean JW; Xu QT; Miller CG; Lawn RM; Scanu AM
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3224-8. PubMed ID: 3472206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a) and thrombocytes: potential mechanisms underlying cardiovascular risk.
    Discepolo W; Wun T; Berglund L
    Pathophysiol Haemost Thromb; 2006; 35(3-4):314-21. PubMed ID: 16877880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein abnormalities in chronic haemodialysis patients.
    Parsy D; Dracon M; Cachera C; Parra HJ; Vanhoutte G; Tacquet A; Fruchart JC
    Nephrol Dial Transplant; 1988; 3(1):51-6. PubMed ID: 3132640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein(a). A potential bridge between the fields of atherosclerosis and thrombosis.
    Scanu AM
    Arch Pathol Lab Med; 1988 Oct; 112(10):1045-7. PubMed ID: 2972266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipolytic degradation of human very low density lipoproteins by human milk lipoprotein lipase: the identification of lipoprotein B as the main lipoprotein degradation product.
    Alaupovic P; Wang CS; McConathy WJ; Weiser D; Downs D
    Arch Biochem Biophys; 1986 Jan; 244(1):226-37. PubMed ID: 3080947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of lipoprotein(a) assembly: a study of wild-type and mutant apolipoprotein(a) phenotypes isolated from human and rhesus monkey lipoprotein(a) under mild reductive conditions.
    Edelstein C; Mandala M; Pfaffinger D; Scanu AM
    Biochemistry; 1995 Dec; 34(50):16483-92. PubMed ID: 8845377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative measurement of lipoprotein particles containing both apolipoprotein AIV and apolipoprotein B in human plasma by a noncompetitive ELISA.
    Ferrer F; Bigot-Corbel E; N'Guyen P; Krempf M; Bard JM
    Clin Chem; 2002 Jun; 48(6 Pt 1):884-90. PubMed ID: 12029004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.